Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Phospholamban Stories

2013-01-23 08:29:15

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that the United States Patent and Trademark Office (USPTO) issued a notice of allowance for U.S. Patent Application No.: 13/145,787 with claims that cover methods for identifying compounds that modulate Sarco/Endoplamic Reticulum Calcium ATPase (SERCA) and methods for identifying compounds that...

2011-09-18 07:00:00

BOSTON, Sept. 18, 2011 /PRNewswire/ -- At the 15th Annual Scientific Meeting of the Heart Failure Society of America (HFSA), Dr. Christine E. Seidman will present the 5th Distinguished Lecture in Basic Science on "Genetic Bases of Dilated Cardiomyopathy." Dr. Seidman's presentation will kick-off the basic research program within the meeting, and will provide an update on her outstanding research, which has pioneered the idea that genetic defects are a common cause of dilated...

2010-11-17 17:27:02

Researchers at UC have found a potential genetic target for heart disease, which could lead to therapies to prevent the development of the nation's No. 1 killer in its initial stages. These findings will be presented for the first time at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 17. The study, led by WenFeng Cai, PhD, a postdoctoral fellow under the direction of Litsa Kranias, PhD, AHA distinguished scientist and Hanna Chair in Cardiology in the department of...